"Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?": Comment from Seitz et al.
作者信息
Seitz Rainer, Gürtler Lutz, Schramm Wolfgang
机构信息
Paul-Ehrlich-Institut, Langen, Germany.
Max von Pettenkofer Institut, Ludwig-Maximilians University (LMU), Munich, Germany.
出版信息
J Thromb Haemost. 2023 Mar;21(3):704-705. doi: 10.1016/j.jtha.2023.01.005.
Abstract
摘要
相似文献
1
"Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?": Comment from Seitz et al.“新冠病毒感染中的血栓炎症：α2巨球蛋白能否帮助控制病情？”：来自塞茨等人的评论
J Thromb Haemost. 2023 Mar;21(3):704-705. doi: 10.1016/j.jtha.2023.01.005.
2
Thromboinflammation in COVID-19: Can α -macroglobulin help to control the fire?COVID-19 中的血栓炎症：α-巨球蛋白能否有助于控制炎症之火？
J Thromb Haemost. 2021 Feb;19(2):351-354. doi: 10.1111/jth.15190. Epub 2020 Dec 19.
3
COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher α -Macroglobulin macroglobulin (α2-M)?新型冠状病毒肺炎相关凝血病——假说：儿童是否因较高的α2-巨球蛋白（α2-M）增强凝血酶抑制作用而受到保护？
J Thromb Haemost. 2020 Sep;18(9):2416-2418. doi: 10.1111/jth.15013.
4
Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation.细胞外囊泡：脓毒症和 COVID-19 相关血栓炎症机制中的新角色。
Int J Mol Sci. 2023 Jan 18;24(3):1920. doi: 10.3390/ijms24031920.
5
Thromboinflammation as a Driver of Venous Thromboembolism.血栓炎症作为静脉血栓栓塞症的驱动因素。
Hamostaseologie. 2021 Dec;41(6):428-432. doi: 10.1055/a-1661-0257. Epub 2021 Dec 23.
6
Molecular form and concentration of serum α-macroglobulin in diabetes.血清α-巨球蛋白的分子形式和浓度在糖尿病中的变化。
Sci Rep. 2019 Sep 10;9(1):12927. doi: 10.1038/s41598-019-49144-7.
7
Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes.与 COVID-19 及其他促血栓形成表型相关的炎症反应。
Reumatol Clin (Engl Ed). 2022 Jan;18(1):1-4. doi: 10.1016/j.reumae.2020.06.007. Epub 2020 Oct 15.
8
A commentary on "Thromboinflammation in long COVID - the elusive key to post-infection sequelae?".关于“长新冠中的血栓炎症——感染后后遗症的 elusive 关键？”的评论
J Thromb Haemost. 2023 Aug;21(8):2061-2063. doi: 10.1016/j.jtha.2023.05.018.
9
Apolipoprotein E-Containing Lipoproteins and LRP1 Protect From NMDA-Induced Excitotoxicity Associated With Reducing α2-Macroglobulin in Müller Glia.载脂蛋白 E 脂蛋白和 LRP1 通过降低 Müller 胶质细胞中的α2-巨球蛋白来保护 NMDA 诱导的兴奋性毒性。
Invest Ophthalmol Vis Sci. 2021 Oct 4;62(13):23. doi: 10.1167/iovs.62.13.23.
10
Letter by Brambilla et al Regarding Article, "Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia".布兰比拉等人就“血小板促进新冠病毒肺炎中的血栓炎症”一文所写的信。
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):e183-e184. doi: 10.1161/ATVBAHA.120.315867. Epub 2021 Feb 24.
引用本文的文献
1
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.严重 COVID-19 患者外周血单个核细胞细胞外基质重塑途径：一项探索性研究。
Front Immunol. 2024 Jun 18;15:1379570. doi: 10.3389/fimmu.2024.1379570. eCollection 2024.
2
Proteomics Clustering Research of ITRAQ Markers in Plasma of AIDS Patients with Different Chinese Medicine Syndromes.艾滋病不同中医证型患者血浆中ITRAQ标记物的蛋白质组学聚类研究
Iran J Public Health. 2024 Feb;53(2):376-386. doi: 10.18502/ijph.v53i2.14922.
本文引用的文献
1
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.新冠肺炎危重症患者抗凝和抗血小板治疗预防静脉和动脉血栓栓塞事件的研究（COVID-PACT）
Circulation. 2022 Nov;146(18):1344-1356. doi: 10.1161/CIRCULATIONAHA.122.061533. Epub 2022 Aug 29.
2
Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.新冠病毒肺炎中的血栓炎症与抗栓治疗：不断积累的证据与现状
JAMA. 2022 Apr 5;327(13):1234-1235. doi: 10.1001/jama.2022.2361.
3
Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?减轻全球脓毒症负担：这会是新冠疫情留下的一项积极遗产吗？
Intensive Care Med. 2021 Jul;47(7):733-736. doi: 10.1007/s00134-021-06409-y. Epub 2021 Jun 16.
4
Anticoagulation in COVID-19: reaction to the ACTION trial.新型冠状病毒肺炎中的抗凝治疗：对ACTIV试验的反应
Lancet. 2021 Jun 12;397(10291):2226-2228. doi: 10.1016/S0140-6736(21)01291-5.
5
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.新型冠状病毒肺炎相关凝血障碍：抗凝治疗的当前认识和指南。
Heart Lung. 2021 Mar-Apr;50(2):357-360. doi: 10.1016/j.hrtlng.2021.01.011. Epub 2021 Jan 20.
6
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.中性粒细胞胞外诱捕网的循环标志物对COVID-19患者具有预后价值。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994. doi: 10.1161/ATVBAHA.120.315267. Epub 2020 Dec 3.
7
Thromboinflammation in COVID-19: Can α -macroglobulin help to control the fire?COVID-19 中的血栓炎症：α-巨球蛋白能否有助于控制炎症之火？
J Thromb Haemost. 2021 Feb;19(2):351-354. doi: 10.1111/jth.15190. Epub 2020 Dec 19.
8
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.血小板病和血管内皮病：COVID-19 血栓炎症的重要促成因素。
Nat Rev Cardiol. 2021 Mar;18(3):194-209. doi: 10.1038/s41569-020-00469-1. Epub 2020 Nov 19.
9
"War to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients.“刀兵相见”对抗血栓炎症，保护 COVID-19 患者的内皮功能。
Crit Care. 2020 Jun 19;24(1):365. doi: 10.1186/s13054-020-03060-9.
10
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
Zotero 插件